• 1. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 2. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 3. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 4. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 5. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Aminopiperidines

Recent Advances in the Study of N-cyclopropyl-1-propylpiperidin-4-amine (CAS: 387358-45-4)

N-cyclopropyl-1-propylpiperidin-4-amine (CAS: 387358-45-4) is a chemical compound that has garnered significant attention in recent years due to its potential applications in the field of chemical biology and pharmaceutical research. This compound, characterized by its unique piperidine and cyclopropyl structural motifs, has been the subject of various studies aimed at exploring its pharmacological properties, synthetic pathways, and therapeutic potential. The following sections provide a comprehensive overview of the latest research findings related to this compound, highlighting its significance in the context of drug discovery and development.

Recent studies have focused on elucidating the molecular mechanisms underlying the biological activity of N-cyclopropyl-1-propylpiperidin-4-amine. One notable area of investigation is its interaction with specific neurotransmitter receptors, particularly those involved in the modulation of central nervous system (CNS) functions. Preliminary data suggest that this compound exhibits affinity for certain G-protein coupled receptors (GPCRs), which are critical targets for the treatment of neurological and psychiatric disorders. Researchers have employed advanced techniques such as molecular docking and in vitro binding assays to characterize these interactions, providing valuable insights into the compound's potential as a lead molecule for CNS drug development.

In addition to its receptor-binding properties, the synthetic accessibility of N-cyclopropyl-1-propylpiperidin-4-amine has also been a focal point of recent research. Several studies have reported optimized synthetic routes that improve yield and purity, making the compound more amenable to large-scale production. For instance, a 2023 study published in the Journal of Medicinal Chemistry described a novel catalytic method for the efficient synthesis of this compound, leveraging palladium-catalyzed cross-coupling reactions. Such advancements are crucial for facilitating further pharmacological evaluations and preclinical studies.

The therapeutic potential of N-cyclopropyl-1-propylpiperidin-4-amine extends beyond CNS applications. Emerging evidence indicates that this compound may also possess anti-inflammatory and analgesic properties, as demonstrated in recent in vivo studies. Animal models of chronic pain and inflammation have shown promising results, with the compound exhibiting efficacy comparable to existing therapeutics but with a potentially improved safety profile. These findings underscore the versatility of N-cyclopropyl-1-propylpiperidin-4-amine and its potential as a multi-target agent in drug development.

Despite these encouraging results, challenges remain in the development of N-cyclopropyl-1-propylpiperidin-4-amine as a viable therapeutic agent. Issues such as pharmacokinetic optimization, toxicity profiling, and formulation stability need to be addressed in future studies. Nevertheless, the compound's unique structural features and broad biological activity make it a compelling candidate for further investigation. Ongoing research efforts are expected to shed more light on its mechanisms of action and therapeutic applications, paving the way for its eventual translation into clinical use.

In conclusion, N-cyclopropyl-1-propylpiperidin-4-amine (CAS: 387358-45-4) represents a promising area of research in the chemical biology and pharmaceutical fields. Its diverse pharmacological properties, coupled with advances in synthetic methodologies, highlight its potential as a lead compound for the development of novel therapeutics. As research continues to unfold, this compound is likely to play an increasingly important role in addressing unmet medical needs across a range of disease areas.

• 62813-02-9(1-Cyclopropylpiperidin-4-amine)
• 73579-08-5(N,1-dimethylpiperidin-4-amine)
• 145932-69-0(2-Piperidineethanamine, N,N-dibutyl-)
• 1176419-75-2(1-cyclopropyl-4-piperidinamine Dihydrochloride)
• 387358-48-7(Cyclopropylmethylpiperidin-4-ylamine)
• 4897-50-1(1,4'-bipiperidine)
• 1197237-40-3(N-Cyclopropyl-N-methyl-4-piperidinamine Hydrochloride)
• 76272-56-5(endo-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine)
• 50533-97-6(N,N-Dimethylpiperidin-4-amine)
• 433227-41-9(8-Azabicyclo[3.2.1]octan-3-amine,8-cyclopropyl-, (3-endo)-)